Skip to content
lifestyle.pluralist.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
August 4, 2026
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
February 12, 2026
←
Previous Page
1
2